Alliance Pharma Regulatory News (APH)

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Appointment of Non-Executive Director

Alliance Pharma plc ("Alliance" or the "Company") is pleased to announce the appointment of Nigel Clifford as an independent Non-Executive Director of the Company. Nigel will join the Board with immediate effect.

Nigel is Chief Executive of Procserve Holdings Limited, a leading company in enabling secure transactions online. He is also currently a non-executive director of Anite plc. He has previously held senior positions at Micro Focus International plc, Nokia, Symbian Software Ltd, Tertio Telecoms Limited, Cable and Wireless plc, Glasgow Royal Infirmary NHS Trust and BT plc.

Commenting on the appointment, Andrew Smith, Chairman of Alliance, said:

"We are delighted to welcome Nigel to the Board of Alliance. His breadth of business experience and his significant exposure to international and European markets make him a strong addition to the Alliance team."

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies. Nigel Richard Clifford, aged 55 years, has been a director of the following companies during the five years preceding the date of this announcement:

There is no further information to be disclosed pursuant to Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

 For further information:

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.